Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis

Clinical trial NCT07235644 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07235644
Sponsor: Uppsala University
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

MS (Multiple Sclerosis)Multiple Sclerosis (MS) - Relapsing-remitting Multiple Sclerosis (Relapsing Remitting)

Start date: 2025-01-01
Primary completion: 2025-12-30
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.